Aerosols of hyaluronan partially prevent bronchoconstriction induced by ultrasonically nebulised distilled water in asthmatics

GIMT - Giornale Italiano delle Malattie del Torace

Volumn 60, Issue 4, 2006, Pages 243-248

  Allegra, L ^a   Dellan Patrona, S ^a   Comi, A ^a   Fasano, V ^a   Longo, L ^a   Terzano, C ^a   Petrigni, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Asthma; Bronchial challenge; Distilled water aerosol; Hyaluronic acid; Matrix; Ultrasonic nebulisation

Indexed keywords

HYALURONIC ACID; SODIUM CHLORIDE; WATER;

ADOLESCENT; ADULT; AEROSOL; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DRUG DOSAGE FORM; DRUG MECHANISM; FEMALE; HUMAN; MALE; NEBULIZATION; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; ULTRASOUND;

EID: 33846553090     PISSN: 11270810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. O'Regan M, Martini L., Crescenzi F, De Luca C, Lansing M. Molecular mechanisms and genetics of hyaluronan biosynthesis. Intern J Biol Macromol 1994; 16:283-286.
2. Bhattacherya J, Cruz T, et al. Hyaluronan affects extravascular water in lung of anesthetized rabbits. J Appl. Physiol 1989; 66:2595-2599.
3. Laurent UBG, Reed RK. Turnover of hyaluronan in the tissues. Adv Drug Delivery Rev 1991; 7:237-256.
4. Reed RK, Laurent UBG. Turnover of hyaluronan in the microcirculation. Am Rev Respir Dis 1992; 146:537-39.
5. Rosenberg RC, Varma R. An overview of proteoglycans in physiology and pathology. In: Varma RS & Varma R (eds). Glycosaminoglycans and Proteoglycans in Physiological and Pathological Processes of Body Systems. Basel: Karger, 1982: 1-4.
6. Toole BP. Glycosaminoglycans and morphogenesis. In: Hay ED (ed.). Cell Biology and Extracellular Matrix. New York: Plenum, 1991:259-294.
7. Forrester JV, Wilkinson PC. Inhibition of leukocyte locomotion by hyaluronic acid. J Cell Sci 1981; 48:315-331.
8. Partsch G, Schwartzer Ch, et al. Modulation of chemyotaxis and migration of PMN cells by hyaluronic acid. Z Rheumatol 1989; 48:123-128.
9. Forrester JV, Lackie jm. Effect of hyaluronic acid on neutrophil adhesion. J Cell Sci 1981; 50:329-344.
10. Reed RK, Lilja K, Laurent TC. Hyaluronan in the rat with special references to the skin. Acta Physiol Scand 1988; 134:405-411.
11. Fraser JRE, Kimpton WG, Laurent TC, et al. Uptake and degradation of hyaluronan in lymphatic tissue. Biochem J 1988; 256:153-158.
12. Smedrson B, Perthof H, Gustavson S, Laurent TC. Scavenger function of the liver endothelial cell. Biochem J 1990; 266:313-327.
13. Prehm P. Hyaluronate is synthetized at plasma membranes. Biochem J 1984; 220:597-600.
14. Turley EA. Hyaluronan-binding proteins and receptors. Adv Drug Delivery Rev 1991; 7:257-264.
15. Antonelli A, D'Amore PA. Density-dependent expression of hyaluronic acid binding to vascular cells in vitro. Microvase Res 1991; 41:239-251.
16. Clarke DN, Sirs JA. Hyaluronic acid and erythrocyte flexibility Intern J Microcirc Clin Exp 1988 (Special Issue); S153.
17. Balasz EA, Denlinger JL. The role of hyaluronic acid in arthritis and its therapeutic use. In: Peyron JC, et al (eds). Osteoarthritis Current Clinical and Fundamental Problems. Basel: Geigy, 1984:165-174.
18. Brandt K. Modification of chemiotaxis by sinovialfluid hyaluronate. Arthr Rheum 1970; 13:308-309.
19. Knudson JB, Knudson W. Hyaluronic-binding proteins in development tissue omeosthasys and disease. FASEB J 1993; 7:1233-1241.
20. Balazs EA, Lechiner A. Cross-linked gels of hyaluronic acid used as rug delivery systems and in cosmetic formulations. Biomatrix Inc, 1997.
21. McDonald CC, Kaye SB, et al. A randomised, crossover, multicentre study to compare the performance of 0.01% (w/v) sodium hyaluronate with 1.4% (w/v) polyvinyl alcohol in the alleviation of symptoms associated with dry eye syndrome. Eye 2002; 16:601-607.
22. Lever R, Page C. Glycosaminoglycans, airways inflammation and bronchial hyperresponsiveness. Pulm Pharmacol Ther 2001; 14:249-254.
23. Ahmed T, Abraham WM, D'Brot J. Effects of inhaled heparin on immunologic and non-immunologic bronchoconsctrictor responses in sheep. Am Rev Respir Dis 1992; 145:566-570.
24. Ahmed T, Garrigo J, Danta I. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N Engl J Med 1993; 329:90-95.
25. Garrigo J, Danta I, Ahmed T: Time course of the protective effect of inhaled heparin on exercise-induced asthma. Am J Respir Crit Care Med 1996; 153:1702-1707.
26. Ahmed T, Gonzales BJ, Danta I. Prevention of exercise-induced bronchoconstriction by inhaled low-molecular-weight heparin. Am J Respir Crit Care Med 1999; 160:576-581.
27. Tranfa CM, Vatrella A, Parrella R, Pelaia G, Bariffi F, Marsico S. Effect of inhaled heparin on water-induced bronchoconstriction in allergic asthmatics. Eur J Clin Pharmacol 2001; 57:5-9.
28. Cantor JO, Cerreta JM, et al. Modulation of airspace enlargement in elastase-induced emphysema by intratracheal instillment of hyaluronidase and hyaluronic acid. Expt1 Lung Res 1995; 21:423-426.
29. Venge P., Pedersen B, et al. Subcutaneous administration of hyaluronan reduce the number of infectious exacerbations in patients with chronic bronchitis. Am J Respir Crit Care Med 1996; 153:312-316.
30. Petrigni G., Comi A.L., Guerra S., Longo L., Misuraca C., Capone P., Ceriotti L., Allegra L. Hyaluronic acid in pediatric patients with exercise-induced asthma. Eur Respir J 2000; 16 (suppl.31):307s.
31. Petrigni G., Allegra L., Aerosolised hyaluronic acid prevents exercise-induced bronchoconstriction, suggesting novel hypotheses on the correction of matrix defects in asthma. Pulm Pharm and Ther 2005, accepted, in press.
32. Petrigni G., Guerra S., Comi A.L., Misuraca C., Allegra L. Hyaluronic acid, a novel way of protecting asthmatics from non-specific bronchoprovocation. Eur Respir J 2000; 16 (suppl.31):458s.
33. Goh LT. Effect of colture conditions on rates of intrinsic hyaluronic acid production by Streptococcus equi spp. Zoepidermicus. Biotechnol Letters 1998; 16:507-512.
34. Allegra L., Bianco S. Non-specific bronchoreactivity obtained with ultrasonic aerosol of distilled water. Eur J Respir Dis 1980; 61 (Suppl 106):41-49.
35. Granger HJ. Physicochemical properties of the extracellular matrix. In: Hargens AR (ed.). Tissues Fluid Pressure and Composition. Baltimore: Williams and Wilkins, 1981: 43-61.
36. Bothner H, Wik O. Rheology of hyaluronate. Acta Otolarynolaryngol (Suppl) 1987; 442:25-30.
37. Bert JL, Pierce RH. The interstitium and microvascular exchange. In: Renkin EM (ed). Handbook of Physiology. Section 2: The Cardiovascular System. Vol IV, Pt.1: Microcirculation. Bethesda: American Physiological Society, 1984: 521-547.
38. Granger HJ, Laine GA, Barnes JE, Lewis RE. Dynamics and control of transmicrovascular fluid exchange. In: Staub NC, et al (eds.). Edema. New York: Raven Press, 1984:189-228.
39. Reed RK, Bowen BD, Bert JL. Microvascular exchange and interstitial volume regulation in the rat: implication of the model. Am J Physiol 1989; 257 H:2081-2091.
40. Laurent TC, et al. On the interaction between polysaccharides and other macromolecules. Biochem Biophys Acta 1963; 78:351-359.
41. Ialenti A, DiRosaM: Hyaluronic acid modulates acute and chronic inflammation. Agents and Actions 1994; 43:44-47.
42. Cantor JO, Cerreta JM, Armand G, Osman M, Turino GM. The pulmonary matrix, glycosaminoglycans and pulmonary emphysema. Connect Tissue Res 1999; 40:97-1